Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence

BACKGROUND: There is no randomized clinical trials with recurrence of atherosclerotic cardiovascular disease (ASCVD) as a major outcome with rosuvastatin. In order to analyze potential differences in the clinical response to atorvastatin and rosuvastatin in secondary ASCVD prevention, we have analyz...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lipids Health Dis
Autors principals: Perez-Calahorra, Sofía, Laclaustra, Martin, Marco-Benedi, Victoria, Pinto, Xavier, Sanchez-Hernandez, Rosa M., Plana, Núria, Ortega, Emilio, Fuentes, Francisco, Civeira, Fernando
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905000/
https://ncbi.nlm.nih.gov/pubmed/31829197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-019-1153-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars